Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech venture capital
Biotech
Will COINS Act kill China biotech licensing boom?
Amid China’s rapid biotech ascent, a growing chorus in the U.S. wants biotechnology added to the COINS Act to restrict outbound capital flows.
Angus Liu
May 26, 2026 3:50pm
With $30M, Oorja Bio breathes new life into fibrosis candidate
May 20, 2026 10:31am
Fierce Biotech Fundraising Tracker '26: Accro, Create & more
May 19, 2026 10:00am
Lauxera raises a hefty €520M for health, medtech companies
May 19, 2026 8:00am
Rebranded biotech lands $125M for rescued Galapagos assets
Apr 28, 2026 7:00am
New Flagship biotech circles in on new DNA drug class
Apr 21, 2026 6:30am
